<DOC>
	<DOCNO>NCT00932100</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy REG1 anticoagulation System Acute Coronary Syndrome ( ACS ) patient undergo cardiac catheterization .</brief_summary>
	<brief_title>A Study Assessing REG1 Anticoagulation System Compared Heparin Subjects With Acute Coronary Syndrome</brief_title>
	<detailed_description>Primary Outcome Bleeding Secondary Outcome Ischemia</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Chest pain ischemic symptom minimum 10 minute duration within 72 hour anticipate cardiac catheterization ; At least one follow criterion meet : 1 . New presumably new STsegment depression least 1 mm transient ( 30 minute ) STsegment elevation least 1 mm 2 contiguous lead ; 2 . Elevated troponin I , T , creatine phosphokinaseMB isoenzyme level within 24 hour sign consent define universal MI definition 3 . Documented coronary artery disease evidence prior angiography , prior angioplasty , bypass graft surgery , myocardial infarction Acute STsegment elevation myocardial infarct Anticipated inability perform angiography within 24 hour dose Evidence clinical instability Contraindications anticoagulant use Recent cardiac intervention Clinically abnormal laboratory test finding screen Subject pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>ACS</keyword>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Catheterization</keyword>
</DOC>